Oura announced on Monday that it is launching a new redesigned app experience and a “Cumulative Stress” feature. The company also shared that it is seeking FDA clearance for blood pressure features that provide users with an estimate of the likelihood of hypertension.
The redesigned Oura app introduces more personalization with three main tabs. The Today tab displays the most relevant information for daily decisions, and the Vitals tab provides at-a-glance conditions such as sleep, stress, and cardiovascular trends. The My Health tab offers insight into the user’s long-term well-being, highlighting strengths, trends and opportunities for preventative care. The tab also includes “Habits” and “Routines” sections to show the impact of daily actions.
The app’s redesign also brings improved menstrual cycle information, including a 12-month period view and fertile window predictions, compared to the previous one-month view.
The new Cumulative Stress feature helps users understand how their body accumulates and responds to chronic stress over time. It provides a stress measurement based on the previous month’s data and is updated weekly. A person’s cumulative stress is determined by five factors: sleep continuity, the heart’s stress response, sleep micromovements, temperature regulation, and the impact of activity.
“It’s much more than just counting the hours spent in stressful times,” Oura VP of Consumer Software Product Jason Russell told TechCrunch. “It’s actually measuring different bodily functions indicative of cumulative stress affecting your body. So things like how your heart rate reacts and your heart rate variability after a period of stress are indicative of cumulative stress. Your thermodynamics. How you regulate your temperature during the night, how continuous your sleep is. signatures that would be indicative of your body experiencing high levels of cumulative stress.”
The new feature will roll out globally in the coming weeks.
On the way to developing an FDA-approved blood pressure feature, Oura announced that it is introducing a new Blood Pressure Profile study to explore how the company can detect early signs of hypertension by passively monitoring background baseline signals.
Techcrunch event
San Francisco
|
27-29 October 2025
Oura received Institutional Review Board approval for the study, which begins at the Oura Labs experimental hub in the US later this year. Users participating in the study will be informed of their current risk of hypertension by combining Oura Ring data with a short check-in questionnaire about family history, medication and lifestyle habits. They will receive an assessment that will tell them if they have no signs, moderate symptoms or severe signs of high blood pressure.
Members with severe symptoms will be encouraged to seek professional medical attention. The algorithm will also track changes over time, prompting periodic reviews throughout the study, Oura says.
Monday’s announcement comes a week after Oura raised $900 million in fresh funding led by Fidelity Management & Research Co., with participation from new investor ICONIQ and contributions from Whale Rock and Atreides.
It also comes as Oura recently launched the Oura Ring 4 Ceramic collection, its first charging case, and a new Health Panels feature that allows members to schedule blood donation directly in the Oura app.
